Chapter 15 – Entry Strategy and Strategic Alliances
15-8
ANSWER 2: The statement is basically correct—licensing proprietary technology to
foreign competitors does significantly increase the risk of losing the technology.
QUESTION 3: Discuss how the need for control over foreign operations varies with
firms’ strategies and core competencies. What are the implications of the choice of entry
mode?
ANSWER 3: If a firm’s competitive advantage (its core competence) is based on control
over proprietary technological know-how, licensing and joint venture arrangements
QUESTION 4: A small Canadian firm that has developed some valuable new medical
products using its unique biotechnology know-how is trying to decide how best to serve
the European Union. Its choices are given below. The cost of investment in
manufacturing facilities will be a major one for the Canadian firm, but it is not outside its
reach. If these are the firm’s only options, which one would you advise it to choose?
Why?
• Manufacture the product at home and let foreign sales agents handle marketing.
• Manufacture the products at home and set up a wholly owned subsidiary in
Europe to handle marketing.
• Enter into a strategic alliance with a large European pharmaceutical firm. The
product would be manufactured in Europe by the 50–50 joint venture and
marketed by the European firm.
ANSWER 4: If there were no significant barriers to exporting, then the third option
would seem unnecessarily risky and expensive. After all, the transportation costs required